Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Short-term Investments (2025)

BioAge Labs (BIOA) has disclosed Short-term Investments for 1 consecutive years, with $92.2 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments changed N/A to $92.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $92.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $92.2 million for FY2025, N/A changed from the prior year.
  • Short-term Investments hit $92.2 million in Q4 2025 for BioAge Labs, up from $70.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $92.2 million in Q4 2025 to a low of $63.0 million in Q1 2025.